Akero Therapeutics Inc (NASDAQ:AKRO)

46.77
Delayed Data
As of 3:59pm ET
 -1.19 / -2.48%
Today’s Change
7.52
Today|||52-Week Range
54.88
-14.65%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Skorpios Trust
Sale12/01/20221,636,000$43.50$71.2M+2.43%
White William R /akero/
Chief Financial Officer
Sale12/27/202219,001$49.77$945.7K-5.87%
Harrison Seth L
Director
Sale10/28/202222,096$40.28$890.0K+14.68%
Rolph Timothy
Chief Scientific Officer
Sale10/06/202222,500$39.29$884.0K+19.21%
Harrison Seth L
Director
Sale10/28/202220,338$40.28$819.2K+14.68%
White William R /akero/
Chief Financial Officer
Sale10/13/202220,000$39.82$796.4K+16.48%
Rolph Timothy
Chief Scientific Officer
Sale9/30/202222,500$34.06$766.4K+37.44%
Rolph Timothy
Chief Scientific Officer
Sale9/30/202222,500$31.38$706.1K+37.44%
Cheng Andrew
President & Chief Executive Officer
Sale1/03/202313,200$50.12$661.6K-5.44%
Rolph Timothy
Chief Scientific Officer
Sale12/29/202212,293$51.38$631.6K-13.09%
Page of 8